Authors: Taddei, GL Arganini, L Raspollini, MR Mennonna, P Vannelli, B Nesi, G Buccoliero, AM

Citation: Gl. Taddei et al., Oligodendroglioma: HMB-45 positivity using catalyzed signal amplification method - An immunohistochemical (HMB-45, CD31, p53, Mib-1) and ultrastructural study, APPL IMMUNO, 9(1), 2001, pp. 35-41

Authors: Taddei, GL Buccoliero, AM Caldarella, A Conti, R Di Lorenzo, N Cacciola, F Franchi, A

Citation: Gl. Taddei et al., Cerebellar liponeurocytoma: Immunohistochemical and ultrastructural study of a case, ULTRA PATH, 25(1), 2001, pp. 59-63

Authors: Noci, I Borri, P Bonfirraro, G Chieffi, O Arcangeli, A Cherubini, A Dabizzi, S Buccoliero, AM Paglierani, M Taddei, GL

Citation: I. Noci et al., Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide, BR J CANC, 85(3), 2001, pp. 333-336

Authors: Noci, I Coronnello, M Borri, P Borrani, E Giachi, M Chieffi, O Marchionni, M Paglierani, M Buccoliero, AM Cherubini, A Arcangeli, A Mini, E Taddei, G

Citation: I. Noci et al., Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro, CANCER LETT, 150(1), 2000, pp. 71-78

Authors: Cherubini, A Taddei, GL Crociani, O Paglierani, M Buccoliero, AM Fontana, L Noci, I Borri, P Borrani, E Giachi, M Becchetti, A Rosati, B Wanke, E Olivotto, M Arcangeli, A

Citation: A. Cherubini et al., HERG potassium channels are more frequently expressed in human endometrialcancer as compared to non-cancerous endometrium, BR J CANC, 83(12), 2000, pp. 1722-1729